Avalyn Pharma

Boston, MA · Founded 2011 · In IPO Registration

Avalyn Pharma Inc is a clinical-stage biopharmaceutical company developing inhaled medicines to treat rare respiratory diseases, including pulmonary fibrosis and other interstitial lung diseases… Avalyn Pharma is based in Boston, MA and was founded in 2011. It is valued at about $155 million as of Oct 2026, set by institutional fund marks. It has raised $387 million.

PMV mark · valuation
$155.0M
Oct 2026
Priced at
—
Total raised
$386.7M
Last round
—

Who backs Avalyn Pharma?

28 investors
InvestorType
F-Prime CapitalVenture capital
NorwestVenture capital
Eight RoadsAsset manager
Novo HoldingsOther
Catalio Capital ManagementVenture capital
Wellington ManagementAsset manager
T. Rowe Price Group—
Perceptive AdvisorsHedge fund
Andera PartnersPE / buyout
SR One Capital ManagementOther
+ 18 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Avalyn Pharma investors

28 investors are on record for Avalyn Pharma, including F-Prime Capital, Norwest, Eight Roads and Novo Holdings. By type, the record holds 4 hedge funds, 3 venture capital firms and 2 asset managers.

Free account
More of Avalyn Pharma with a free account
  • ·The complete investor list: 28 names
  • ·Watch Avalyn Pharma: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 28 firms already write checks for companies like Avalyn Pharma. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View